Ann Neurol

1. DE NEELING MGJ, Keulen BJ, Stam MJ, Hubers D, et al
   Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing-Enabled Deep Brain Stimulation.
   Ann Neurol. 2025 Aug 29. doi: 10.1002/ana.78025.
   

   >> Share

   
   

   
   BMC Neurol

2. ERDEM M, Ozdogru D, Soker EB, Ademoglu B, et al
   The potential role of serum and urine galectin-3 values in the diagnosis and staging of Parkinson's disease.
   BMC Neurol. 2025;25:365.
   

   >> Share

   
   
3. YAO X, Wang P, Huang Z, Li L, et al
   Differential gene expression and immune profiling in Parkinson's disease: unveiling potential candidate biomarkers.
   BMC Neurol. 2025;25:354.
   

   >> Share

   
   
4. XIONG Y, Chen C, Shi L, Yang Y, et al
   Risk factors of thoracolumbar fascia injury for patients with Parkinson's disease and construction of a nomogram model.
   BMC Neurol. 2025;25:352.
   

   >> Share

   
   

   
   Exp Brain Res

5. SHAHAM G, Galperin I, Salomon A, Gazit E, et al
   Motor planning stage of gait initiation: effects of aging, Parkinson's disease, and associations with cognitive function.
   Exp Brain Res. 2025;243:201.
   

   >> Share

   
   

   
   J Neuropsychol

6. BEZDICEK O, Motyl J, Nikolai T, Mazancova AF, et al
   Differential cued recall memory impairment in mild cognitive impairment due to Alzheimer's disease versus Parkinson's disease.
   J Neuropsychol. 2025 Aug 28. doi: 10.1111/jnp.70010.
   

   >> Share

   
   

   
   Mov Disord

7. MIMMI S, Parrotta EI, Tolomeo AM, Maisano D, et al
   Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy.
   Mov Disord. 2025;40:1420-1426.
   

   >> Share

   
   
8. ROSSI M, Farris CM, Baiardi S, Giannini G, et al
   Comparison of Two alpha-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism.
   Mov Disord. 2025 Aug 20. doi: 10.1002/mds.70017.
   

   >> Share

   
   
9. PRATUSEVICIUTE N, Lis P, Weber S, Gruchy N, et al
   Functional and Structural Characterization of LRRK2 p.V1447L in Parkinson's Disease.
   Mov Disord. 2025 Jul 30. doi: 10.1002/mds.30284.
   

   >> Share

   
   
10. IKEZAWA J, Yokochi F, Yamaguchi T, Abe K, et al
    Bilateral Effects of Unilateral Pallidothalamic Tractotomy Using Focused Ultrasound in Parkinson's Disease.
    Mov Disord. 2025 Jul 17. doi: 10.1002/mds.30281.
    

    >> Share

    
    
11. CHEN PS, Liu YL, Chiang PT, Tsai HH, et al
    Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals.
    Mov Disord. 2025 Jul 15. doi: 10.1002/mds.30290.
    

    >> Share

    
    
12. BOURQUE M, Morissette M, Bortolato M, Frau R, et al
    Pregnenolone Reduces L-Dopa-Induced Dyskinesias in Female Parkinsonian Monkeys.
    Mov Disord. 2025 Jul 5. doi: 10.1002/mds.30280.
    

    >> Share

    
    

    
    Neurology

13. XUAN Z, Pan Z, Ma C, Lin X, et al
    Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210094.
    

    >> Share

    
    
14. CHAHINE L, Rosso AL, Troidl I, Ganguli M, et al
    Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults.
    Neurology. 2025;105:e214037.
    

    >> Share

    
    
15. SCHULZ RS, Rist PM, Kurth T
    Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210158.
    

    >> Share

    
    
16. GANESH A, Galetta SL
    Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e214084.
    

    >> Share

    
    

    
    PLoS One

17. NOROUZI-GHAZBI S, Mirbaha S, Li Z, Andrysek J, et al
    Gamification-based tele-rehabilitation for physical therapy in patients with Parkinson's disease: A scoping review.
    PLoS One. 2025;20:e0326705.
    

    >> Share

    
    
18. 
    Expression of Concern: The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling.
    PLoS One. 2025;20:e0330958.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share